This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Equine Thromboxane A2 (TXA2) ELISA Kit-Competitive
Product Overview
BioVenic Equine Thromboxane A2 (TXA2) ELISA Kit-Competitive is designed for the quantitative determination of Equine Thromboxane A2 (TXA2) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
Thromboxane A2 (TXA2) is a type of thromboxane produced by activated platelets during hemostasis. It has prothrombotic properties, stimulating the activation of new platelets and increasing platelet aggregation. When TXA2 binds to its receptor, it results in platelet shape change, inside-out activation of integrins, and degranulation. This process strengthens blood clot formation. It has been implicated as an important pathophysiologic mediator of a variety of cardiovascular diseases.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.